1 | Mavrilimumab | [1] Mavrilimumab Mavrilimumab (Mavrilimumab) | [1] Mavrilimumab
Mavrilimumab
(Mavrilimumab) 💬
| [1] CSF2RA CSF2RA 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [2] 41 41, 46 💬
|
2 | Mavrilimumab 10 MG | [1] Mavrilimumab Mavrilimumab (Mavrilimumab) | [1] Mavrilimumab
Mavrilimumab
(Mavrilimumab) 💬
| [1] CSF2RA CSF2RA 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [1] 46 46 💬
|
3 | Mavrilimumab 100 MG | [1] Mavrilimumab Mavrilimumab (Mavrilimumab) | [1] Mavrilimumab
Mavrilimumab
(Mavrilimumab) 💬
| [1] CSF2RA CSF2RA 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [1] 46 46 💬
|
4 | Mavrilimumab 150 MG | [1] Mavrilimumab Mavrilimumab (Mavrilimumab) | [1] Mavrilimumab
Mavrilimumab
(Mavrilimumab) 💬
| [1] CSF2RA CSF2RA 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [1] 46 46 💬
|
5 | Mavrilimumab 30 MG | [1] Mavrilimumab Mavrilimumab (Mavrilimumab) | [1] Mavrilimumab
Mavrilimumab
(Mavrilimumab) 💬
| [1] CSF2RA CSF2RA 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [1] 46 46 💬
|
6 | Mavrilimumab 50 MG | [1] Mavrilimumab Mavrilimumab (Mavrilimumab) | [1] Mavrilimumab
Mavrilimumab
(Mavrilimumab) 💬
| [1] CSF2RA CSF2RA 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | [1] 46 46 💬
|